Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd trading window closed from 01 October 2026 for unaudited Q2 and H1 results ending 30 September 2026; will reopen 48 hours after the announcement/declaration of the unaudited financial results.

Transaction details

• Target: Krishna Institute of Medical Sciences Limited.
• Acquirer: Catalyst Trusteeship Limited (Debenture Trustee) for debenture holders; PACs none.
• Promoter group: acquirer not part of promoter/promoter group.
• Exchanges: BSE Limited and National Stock Exchange of India.
• Encumbrance before: 2,80,08,979 shares (6.66%).
• Mode: pledge of shares in favour of Catalyst Trusteeship Limited.
• Salient features: pledge by Bhaskara Rao Bollineni and Bollineni Seenaiah Naidu.
• Date: 18-Sep-2026.
• Equity capital before: Rs 84,00,12,968 comprising 42,00,06,484 shares (Rs 2 each).
• Equity capital after: Rs 84,00,12,968 comprising 42,00,06,484 shares (Rs 2 each).
• Post-acquisition encumbrance: 2,80,08,979 shares (6.66%).
• Total diluted share capital after: Rs 84,00,12,968 (42,00,06,484 shares).

Meeting Details

• Date: September 22, 2026.
• Event: Anand Rathi Annual Flagship Conference, G-200 Summit 2026.
• Venue: Mumbai, India; Type: Group Meeting; Mode: Physical.
• Organizer: Anand Rathi.
• Purpose: Schedule/intention for Analyst/Institutional Investor meeting.
• Key participant from company: Company Secretary & Compliance Officer.

Meeting Details

• Date of meeting: September 21, 2026; venue: Mumbai, India.
• Event: J.P. Morgan India Conference; type: group meeting.
• Mode: physical (Mumbai venue).
• Purpose: schedule for Analyst/Institutional Investor Meeting.

Parties

• Krishna Institute of Medical Sciences Limited and Sarvottam Health Care Private Limited.

Purpose

• Exclusive Operations & Management to run SHPL hospital in Kakinada for 5 years, with extension.

Key terms

• Exclusive operator rights to KIMS for SHPL hospital.
• Revenue fee of 9% of SHPL's net revenue.
• Net Revenue = gross billed minus concessions/discounts.
• Initial term 5 years, extendable for 5 more years.
• SHPL hospital capacity currently 183 beds.

Related party status

• Not a related party transaction; no promoter/group interest disclosed.

Impact

• Establishes KIMS as exclusive operator, expanding presence in Andhra Pradesh.
• Adds 9% revenue-based fee as new revenue stream.
• Hospital capacity remains 183 beds; potential growth in KIMS footprint.

Regulatory disclosures

• Annexure-A containing SEBI LODR disclosures attached.
• Disclosures uploaded on the company website; Regulation 30 filings.

Termination / amendments

• New agreement; no termination or amendment details disclosed.

Execution details

• Date of agreement: 10 September 2026.

Meeting Details

• Date/Time: Thursday, 10 September 2026 at 2:30 p.m. IST.
• Type/Mode: Group and one-on-one meetings, in person.
• Event: Institutional Investor Meeting hosted by Emkay Global.
• Venue: KIMS Mahadevpura.

Participants

• Key company participants are Company Secretary and Compliance Officer.

Purpose

• Purpose: Intimation of Analyst/Institutional Investor Meeting schedule.

Additional Notes

• Discussions will be based on publicly available information.
• Schedule subject to change.

AGM details

• AGM held on 27-08-2026 via VC/OAVM.
• Total shareholders on record: 97,610.
• Shareholders attended via VC/OAVM: promoters 2, public 69.

Key resolutions

• Adoption of standalone financial statements for year ended Mar 31, 2026.
• Remuneration payable to Cost Auditors for 2026-27 ratified.
• Approval for loans, guarantees, or securities under section 185.
• Approval of overall limits for loans, guarantees, investments under section 186.

Voting results

• Resolution 1 passed with all votes in favour.
• Resolution 2 passed with 74.46% in favour.
• Resolution 3 passed with 99.9999% in favour.
• Resolution 4 passed with 78.38% in favour.
• Resolution 5 passed with 78.50% in favour.

Auditors

• Cost Auditors remuneration for 2026-27 ratified.

Directors

• Director Anitha Dandamudi re-appointed by rotation.

AGM Details

• Date and mode: 27 August 2026, via VC/OAVM.
• Total shareholders on record: 97,610.

Key Resolutions

• Adoption of audited financial statements and reports — Ordinary; passed with notable dissent.
• Re-appointment of Anitha as Director by rotation — Ordinary; passed.
• Remuneration payable to Cost Auditor for 2026-27 — Ordinary; passed.
• Loans/guarantees/securities under section 185 — Ordinary; passed.
• Overall limits for loans/guarantees/investments — Ordinary; passed.

Voting Highlights

• Resolution 1: Passed with notable dissent.
• Resolutions 2–5: Passed with majority in favour.

Director Changes

• Anitha appointed as Director; retires by rotation.

Auditor Appointments

• Cost Auditor remuneration approved for 2026-27.

Material Related Party Transactions

• No material RPTs disclosed.

Other Material Approvals

• Loans/guarantees/securities approvals; investments limits approved.

AGM Details

• Date and time: August 2026, 4:00 PM IST.
• Mode: video conferencing and other audio-visual means (VC/OAVM).
• Attendance: members participated via VC/OAVM.

Key Resolutions

• Ordinary: Adoption of financial statements and board reports.
• Ordinary: Re-appointment of director by rotation.
• Ordinary: Ratification of remuneration for cost auditors.
• Special: Approval for granting loans/guarantees/securities under section 185.
• Special: Approval of overall limits under section 186 for loans/investments/guarantees/securities.

Voting Status

• Voting results to be disseminated; not disclosed in the excerpt.

Auditors

• Statutory auditor attended via VC.
• Secretarial auditor attended via VC.
• Cost auditor remuneration for the year ratified.